Gastric Cancer Survivorship: Multidisciplinary Management, Best Practices and Opportunities.

IF 1.6 Q4 ONCOLOGY

Journal of Gastrointestinal Cancer Pub Date : 2024-06-01 Epub Date: 2024-01-05 DOI:10.1007/s12029-023-01001-7

Era Cobani, Mohammed Najeeb Al Hallak, Anthony F Shields, Jordan Maier, Thomas E Kelly, Niren Naidoo, Miguel Tobon, Steve Kim, Eliza W Beal

{"title":"Gastric Cancer Survivorship: Multidisciplinary Management, Best Practices and Opportunities.","authors":"Era Cobani, Mohammed Najeeb Al Hallak, Anthony F Shields, Jordan Maier, Thomas E Kelly, Niren Naidoo, Miguel Tobon, Steve Kim, Eliza W Beal","doi":"10.1007/s12029-023-01001-7","DOIUrl":null,"url":null,"abstract":"Purpose: Gastric cancer is the 5th most common malignancy worldwide. As early detection increases and treatments for gastric cancer improve, the number of gastric cancer survivors grows.Methods: Here, we review the diagnosis and management of gastric cancer and discuss important considerations for gastric cancer survivorship including cancer surveillance, weight loss, malnutrition, fatigue, specific complications related to surgery and radiation, quality of life in gastric cancer survivorship, health behavior, and models of survivorship.Results: Multimodality therapy with chemotherapy and surgery can result in chronic toxicities in multiple organ systems. This emphasizes the need for a multidisciplinary survivorship care model including cancer surveillance, management of chronic toxicities, and optimization of modifiable risk factors with long-term involvement of appropriate providers.Conclusion: Adequately caring for gastric cancer survivors requires a coordinated, multidisciplinary approach.","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gastrointestinal Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12029-023-01001-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/5 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Gastric cancer is the 5th most common malignancy worldwide. As early detection increases and treatments for gastric cancer improve, the number of gastric cancer survivors grows.

Methods: Here, we review the diagnosis and management of gastric cancer and discuss important considerations for gastric cancer survivorship including cancer surveillance, weight loss, malnutrition, fatigue, specific complications related to surgery and radiation, quality of life in gastric cancer survivorship, health behavior, and models of survivorship.

Results: Multimodality therapy with chemotherapy and surgery can result in chronic toxicities in multiple organ systems. This emphasizes the need for a multidisciplinary survivorship care model including cancer surveillance, management of chronic toxicities, and optimization of modifiable risk factors with long-term involvement of appropriate providers.

Conclusion: Adequately caring for gastric cancer survivors requires a coordinated, multidisciplinary approach.

查看原文本刊更多论文

胃癌幸存者：多学科管理、最佳实践与机遇。

目的：胃癌是全球第五大常见恶性肿瘤。方法：在此，我们回顾了胃癌的诊断和治疗，并讨论了胃癌幸存者的重要注意事项，包括癌症监测、体重减轻、营养不良、疲劳、手术和放疗相关的特殊并发症、胃癌幸存者的生活质量、健康行为和幸存者模式：结果：化疗和手术的多模式治疗可导致多个器官系统的慢性毒性。结果：化疗和手术的多模式治疗可导致多个器官系统的慢性毒性，这就强调了多学科幸存者护理模式的必要性，包括癌症监测、慢性毒性管理以及优化可改变的风险因素，并有适当的医疗服务提供者长期参与：结论：为胃癌幸存者提供充分的护理需要协调的多学科方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Gastrointestinal Cancer ONCOLOGY-

CiteScore

3.80

自引率

0.00%

发文量

121

期刊介绍： The Journal of Gastrointestinal Cancer is a multidisciplinary medium for the publication of novel research pertaining to cancers arising from the gastrointestinal tract.The journal is dedicated to the most rapid publication possible.The journal publishes papers in all relevant fields, emphasizing those studies that are helpful in understanding and treating cancers affecting the esophagus, stomach, liver, gallbladder and biliary tree, pancreas, small bowel, large bowel, rectum, and anus. In addition, the Journal of Gastrointestinal Cancer publishes basic and translational scientific information from studies providing insight into the etiology and progression of cancers affecting these organs. New insights are provided from diverse areas of research such as studies exploring pre-neoplastic states, risk factors, epidemiology, genetics, preclinical therapeutics, surgery, radiation therapy, novel medical therapeutics, clinical trials, and outcome studies.In addition to reports of original clinical and experimental studies, the journal also publishes: case reports, state-of-the-art reviews on topics of immediate interest or importance; invited articles analyzing particular areas of pancreatic research and knowledge; perspectives in which critical evaluation and conflicting opinions about current topics may be expressed; meeting highlights that summarize important points presented at recent meetings; abstracts of symposia and conferences; book reviews; hypotheses; Letters to the Editors; and other items of special interest, including:Complex Cases in GI Oncology: This is a new initiative to provide a forum to review and discuss the history and management of complex and involved gastrointestinal oncology cases. The format will be similar to a teaching case conference where a case vignette is presented and is followed by a series of questions and discussion points. A brief reference list supporting the points made in discussion would be expected.